Camp4 Therapeutics director Andrew J. Schwab disposes of USD 879,374 in common shares
CAMP•Director reports share sales through 5AM Ventures VI
Camp4 Therapeutics director Andrew J. Schwab reported sales totaling 191,865 common shares on Aug. 19-21.
Sales were executed through 5AM Ventures VI at weighted average prices of $4.76, $4.54, and $4.50.
5AM Ventures VI’s holding fell to 2,433,280 shares following the transactions.
